The Wall Street Journal: Bayer to Rethink Roundup Formula for U.S. Consumers — In response to U.S. Judge Vincent Chhabria rejecting the company’s proposed deal to settle all future lawsuits, Bayer said it will pursue several alternative avenues, including evaluating whether to continue using the active ingredient in its popular Roundup weedkiller in the residential U.S. market. The U.S. Environmental Protection Agency maintains that the product is safe and has said it wouldn’t permit a cancer warning.
National Law Review: PFAS Financial World Ticking Time Bomb — Many sectors of the economy will be significantly impacted within the next year by PFAS regulations. The legal minds at National Law Review warn that all companies—not just water utilities responsible for “drinking water”—will be directly impacted.
JD Supra: Are PFAS Air Emission Regulations On The Horizon? — As testing methods are identified, toxicology studies are completed, and transport models tuned, the Environmental Protection Agency may consider rules regulating air emissions of PFAS. Though the agency has not begun any rulemaking efforts to that effect yet, several states have begun to set their own air guidelines for specific PFAS compounds.
The Wall Street Journal: In the War on Cancer, Science Is Winning — Dr. Robin Smith, founder and chairman of Cura Foundation, chronicles the recent accomplishments scientists have made in the fight against cancer. These technologies—including new Crispr gene-editing technology, vaccine and blood test capabilities, and T-cell therapies—prove that “one day ‘the big C’ will be merely another letter of the alphabet.”
NJ Spotlight News: South Jersey Residents Sue Chemical Companies Over ‘Public Health Catastrophe’ — A local battle against toxic chemicals polluting water, soil and air in parts of South Jersey is going to federal court, as multiple lawsuits are being prepared alleging that chemicals emitted by two industrial plants caused birth defects, cancers, and other illnesses in dozens of people. Attorneys are examining about 100 potential personal injury suits stemming from the chemical exposure.